Deepbridge has recently deployed an investment of £250,000 into Levitex Foams Limited, through the Deepbridge Life Sciences EIS fund. This follows on from an initial seed funding investment of £150,000, via the Deepbridge Life Sciences SEIS fund.
About Levitex Foams Ltd
Levitex Foams Ltd has developed a new foam product that aims to redistribute pressure and posture, with a particular focus on users that are bed-bound. Being bed-bound can potentially lead to pressure sores resulting in a worsening of the patient’s general health condition, which could lead to an extended and more costly stay in hospital.
- October 2024 (4)
- September 2024 (4)
- August 2024 (4)
- July 2024 (1)
- June 2024 (3)
- May 2024 (2)
- April 2024 (2)
- March 2024 (3)
- February 2024 (8)
- January 2024 (7)
- December 2023 (1)
- November 2023 (7)
- October 2023 (6)
- September 2023 (4)
- August 2023 (4)
- July 2023 (7)
- June 2023 (5)
- May 2023 (3)